|
|
Last Modified: 8/1/1998  First Published: 2/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
NCCTG-969258 NCI-P97-0126
|
|
|
|
|
|
|
|
Last Modified: 7/5/2006  First Published: 12/1/2001 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Prevention
|
|
|
|
Completed
|
|
|
|
50 to 80
|
|
|
|
NCI
|
|
|
|
MCC-0002 NCI-4031, NCI-P01-0195, NCT00027950
|
|
|
|
|
|
|
|
Last Modified: 11/21/2006  First Published: 2/20/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Prevention, Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
WSU-C-2418 NCT00078923
|
|
|
|
|
|
|
|
Last Modified: 5/28/2008  First Published: 6/22/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Biomarker/Laboratory analysis, Treatment
|
|
|
|
Closed
|
|
|
|
Over 18
|
|
|
|
NCI
|
|
|
|
CCCWFU-98203 CCCWFU-BG03-332, NCT00345813
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
50 to 80
|
|
|
|
Other
|
|
|
|
MCC-12835 NCI #4031, CA 81920, NCT00617617
|
|
|
|
|
|
|
|
Last Modified: 6/1/2000  First Published: 11/1/1997 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Prevention
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
UCMC-CHMC-91-5-3 NCI-P97-0117, NCT00003100
|
|
|
|
|
|
|
|
Last Modified: 10/15/2007  First Published: 8/1/2002 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Biomarker/Laboratory analysis, Treatment
|
|
|
|
Completed
|
|
|
|
45 to 80
|
|
|
|
NCI
|
|
|
|
MCC-0105 NCI-3811, NCI-P02-0216, HLMCC 0105, NCT00042731
|
|
|
|
|
|
|
|
Last Modified: 10/16/2007  First Published: 6/16/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Behavioral study, Educational/Counseling/Training, Supportive care
|
|
|
|
Closed
|
|
|
|
21 and over
|
|
|
|
NCI
|
|
|
|
CCCWFU-98904 NCT00343434
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
45 and over
|
|
|
|
Other
|
|
|
|
PROS0022 97408, NCT00482157, PROS0022, NCT00482157
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Biomarker/Laboratory analysis, Prevention
|
|
|
|
Completed
|
|
|
|
35 to 50
|
|
|
|
Other
|
|
|
|
R14697 07/Q0101/10, NCT00555386
|
|
|
|